<p>A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line <em>Helicobacter pylori</em> eradication: a prospective randomized trial</p>-Reference-Cited by-同舟云学术

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial

Published:2019-09 Issue: Volume:Volume 12 Page:2923-2931
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Tai Wei-Chen,Liang Chih-Ming^ORCID,Bi Kuo-Wei^ORCID,Kuo Chung-Mou,Lu Lung-Sheng,Wu Cheng-Kun,Yang Shih-Cheng,Kuo Yuan-Hung,Lee Chen-Hsiang,Huang Chih-Fang^ORCID,Hsu Chien-Ning^ORCID,Hsu Pin-I,Wu Deng-Chyang^ORCID,Hu Tsung-Hui,Wu Keng-Liang^ORCID,Chuah Seng-Kee^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validated chromatographic approach for determination of two ternary mixtures in newly approved formulations for helicobacter pylori eradication: assessment of greenness profile and content uniformity;BMC Chemistry;2024-06-12

2. Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review;Antibiotics;2023-05-23

3. Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly;Drugs & Aging;2023-01

4. The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance;Biomedical Journal;2020-11

5. Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance;Antibiotics;2020-07-23